Elisabeth Kenne Sarenmalm

Dr. Elisabeth Kenne Sarenmalm

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2017 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
ESElisabeth Kenne Sarenmalm
Elisabeth Kenne Sarenmalm
LMLena B Mårtensson
Lena B Mårtensson
BABengt A Andersson
Bengt A Andersson
PKPer Karlsson
Per Karlsson
IBIngrid Bergh
Ingrid Bergh
Many breast cancer survivors have to deal with a variety of psychological and physiological sequelae including impaired immune responses. The primary purpose of this randomized controlled trial was to determine the efficacy of a mindfulness‐based stress reduction (MBSR) intervention for mood disorders in women with breast cancer. Secondary outcomes were symptom experience, health status, coping capacity, mindfulness, posttraumatic growth, and immune status. This RTC assigned 166 women with breast cancer to one of three groups: MBSR (8 weekly group sessions of MBSR), active controls (self‐instructing MBSR) and non‐MBSR. The primary outcome measure was the Hospital Anxiety and Depression Scale. Secondary outcome measures were: Memorial Symptom Assessment Scale, SF‐36, Sense of Coherence, Five Facets of Mindfulness Questionnaire, and Posttraumatic Growth Index. Blood samples were analyzed using flow cytometry for NK‐cell activity (FANKIA) and lymphocyte phenotyping; concentrations of cytokines were determined in sera using commercial high sensitivity IL‐6 and IL‐8 ELISA (enzyme‐linked immunosorbent assay) kits. Results provide evidence for beneficial effects of MBSR on psychological and biological responses. Women in the MBSR group experienced significant improvements in depression scores, with a mean pre‐MBSR HAD‐score of 4.3 and post‐MBSR score of 3.3 (P = 0.001), and compared to non‐MBSR (P = 0.015). Significant improvements on scores for distress, symptom burden, and mental health were also observed. Furthermore, MBSR facilitated coping capacity as well as mindfulness and posttraumatic growth. Significant benefits in immune response within the MBSR group and between groups were observed. MBSR have potential for alleviating depression, symptom experience, and for enhancing coping capacity, mindfulness and posttraumatic growth, which may improve breast cancer survivorship. MBSR also led to beneficial effect on immune function; the clinical implications of this finding merit further research.

12 September 2011 in Psycho-Oncology
Verified
Journal Article
Closed access
PDF file
ESElisabeth Kenne Sarenmalm
Elisabeth Kenne Sarenmalm
MBMaria Browall
Maria Browall
LPL.‐O. Persson
L.‐O. Persson
JFJ. Fall‐Dickson
J. Fall‐Dickson
FGFanny Gaston‐Johansson
Fanny Gaston‐Johansson

1 April 2014 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
ESElisabeth Kenne Sarenmalm
Elisabeth Kenne Sarenmalm
MBMaria Browall
Maria Browall
FGFannie Gaston-Johansson
Fannie Gaston-Johansson

6 February 2018 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
YJYvonne A. Johansson
Yvonne A. Johansson
IBIngrid Bergh
Ingrid Bergh
IEIréne Ericsson
Iréne Ericsson
ESElisabeth Kenne Sarenmalm
Elisabeth Kenne Sarenmalm
Delirium is common in older hospitalized patients, and is associated with negative consequences for the patients, next of kin, healthcare professionals and healthcare costs. It is important to understand its clinical features, as almost 40% of all cases in hospitals may be preventable. Yet, delirium in hospitalized patients is often unrecognized and untreated. Few studies describe thoroughly how delirium manifests itself in older hospitalized patients and what actions healthcare professionals take in relation to these signs. Therefore, the aim of this study was to describe signs of delirium in older hospitalized patients and action taken by healthcare professionals, as reported in patient records. Patient records from patients aged ≥65 (n = 286) were retrospectively reviewed for signs of delirium, which was found in 78 patient records (27%). Additionally, these records were reviewed for action taken by healthcare professionals in relation to the patients’ signs of delirium. The identified text was analyzed with qualitative content analysis in two steps. Healthcare professionals responded only in part to older hospitalized patients’ needs of care in relation to their signs of delirium. The patients displayed various signs of delirium that led to a reduced ability to participate in their own care and to keep themselves free from harm. Healthcare professionals met these signs with a variation of actions and the care was adapted, deficient and beyond the usual care. A systematic and holistic perspective in the care of older hospitalized patients with signs of delirium was missing. Improved knowledge about delirium in hospitals is needed in order to reduce human suffering, healthcare utilization and costs. It is important to enable older hospitalized patients with signs of delirium to participate in their own care and to protect them from harm. Delirium has to be seen as a preventable adverse event in all hospitals units. To improve the prevention and management of older hospitalized patients with signs of delirium, person-centered care and patient safety may be important issues.

11 September 2019 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
PWPär Wennberg
Pär Wennberg
MMMargareta Möller
Margareta Möller
JHJohan Herlitz
Johan Herlitz
ESElisabeth Kenne Sarenmalm
Elisabeth Kenne Sarenmalm
Background: Impaired cognition is a major risk factor for perioperative delirium. It is essential to provide good pain control in patients with hip fractures and especially important in patients with severely impaired cognitive status, as they receive less pain medication, have poorer mobility, poorer quality of life and higher mortality than patients with intact cognition. The purpose of this study was to examine the association between preoperative pain management with nerve blocks and cognitive status in patients with hip fractures during the perioperative period.Methods: One hundred and twenty-seven patients with hip fractures participating in a double-blind, randomised, controlled trial were included in this study. At hospital admission, a low-dose fascia iliaca compartment block (FICB) was administered as a supplement to regular analgesia. Cognitive status was registered on arrival at hospital before FICB and on the first postoperative day using the Short Portable Mental Status Questionnaire.Results: Changes in cognitive status from arrival at hospital to the first postoperative day showed a positive, albeit not significant, trend in favour of the intervention group. The results also showed that patients with no or a moderate cognitive impairment received 50% more prehospital pain medication than patients with a severe cognitive impairment. FICB was well tolerated in patients with hip fractures.Conclusion: Fascia iliaca compartment block given to patients with hip fractures did not affect cognitive status in this study. Patients with a cognitive impairment may receive inadequate pain relief after hip fracture and this discrimination needs to be addressed in further studies.Trial registration: EudraCT number2008–004303-59date of registration: 2008-10-24.

1 May 2019 in International Journal of Orthopaedic and Trauma Nursing
Verified
Journal Article
Open access
PWPär Wennberg
Pär Wennberg
RNRolf Norlin
Rolf Norlin
JHJohan Herlitz
Johan Herlitz
ESElisabeth Kenne Sarenmalm
Elisabeth Kenne Sarenmalm
MMMargareta Möller
Margareta Möller
Pain management in patients with hip fractures is a major challenge for emergency care. The objective of this study was to evaluate whether the supplementation of pre-operative analgesia with low-dose fascia iliaca compartment block (FICB) compared with placebo would improve pain relief in patients with hip fractures. A double-blind, randomized, controlled trial was conducted on 127 patients. At hospital admission, a low-dose FICB was administered to patients with hip fractures as a supplement to regular pre-operative analgesia. Patients with and without cognitive impairment were included. The instruments used were a visual analogue scale (VAS), a numerical rating scale and a tool for behavior related pain assessment. The primary endpoint was the change in reported pain on movement from hospital admission to two hours after FICB. The intervention group showed improved pain management by mean VAS score for pain on movement compared with the control group (p = 0.002). Our results support the use of low-dose FICB as a pain-relieving adjuvant to other analgesics when administered to patients with a hip fracture.